Atlas Trials

Krystal Biotech, Inc.

18 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Krystal Biotech, Inc.

RecordFirmDate
A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey Disease (NCT07717346)Krystal Biotech, Inc.2026-05-06
A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis (NCT06999733)Krystal Biotech, Inc.2025-07-07
A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa (NCT07016750)Krystal Biotech, Inc.2025-06-20
A Study Assessing KB304 for the Treatment of Wrinkles in Women (NCT06724900)Krystal Biotech, Inc.2024-11-20
A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB) (NCT06563414)Krystal Biotech, Inc.2024-08-02
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs (NCT06228326)Krystal Biotech, Inc.2024-04-17
A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency (NCT06049082)Krystal Biotech, Inc.2024-02-15
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors (NCT05970497)Krystal Biotech, Inc.2023-10-31
A Study Assessing KB407 for the Treatment of Cystic Fibrosis (NCT05504837)Krystal Biotech, Inc.2023-06-30
Topical KB105 for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI) (NCT05735158)Krystal Biotech, Inc.2023-03-01
A Study of Inhaled KB407 for the Treatment of Cystic Fibrosis (NCT05095246)Krystal Biotech, Inc.2022-03-08
A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa (NCT04917874)Krystal Biotech, Inc.2021-05-25
Long-Term Follow-up Protocol (NCT04917887)Krystal Biotech, Inc.2021-05-25
A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions (NCT04540900)Krystal Biotech, Inc.2020-10-07
Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB (NCT04491604)Krystal Biotech, Inc.2020-08-17
The Natural History of Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB) (NCT04214002)Krystal Biotech, Inc.2020-01-01
Topical KB105 Gene Therapy for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI) (NCT04047732)Krystal Biotech, Inc.2019-08-27
A Phase I/II Study of KB103, a Topical HSV1-COL7, on DEB Patients (NCT03536143)Krystal Biotech, Inc.2018-05-06

Track Krystal Biotech, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.